IFN-γ induces coordinate expression of MHC class I-mediated antigen presentation machinery molecules in adult mouse Schwann cells

NeuroReport

Volumn 9, Issue 9, 1998, Pages 2071-2075

  Tsuyuki, Yoshiharu ^a   Fujimaki, Haruka ^a   Hikawa, Naoshi ^a   Fujita, Kiyohide ^a   Nagata, Toshi ^a,b   Minami, Mutsuhiko ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

LMP; MHC class I molecule; Schwann cells; TAP; 2 Microglobulin

Indexed keywords

BETA 2 MICROGLOBULIN; COMPLEMENTARY DNA; CYTOKINE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; PROTEASOME;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHWANN CELL;

EID: 0032557840     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199806220-00029     Document Type: Article

References (24)

1. Armati PJ and Pollard JD. Baillières Clin Neurol 5, 47-64 (1996).
2. York IA and Rock KL. Annu Rev Immunol 14, 369-396 (1996).
3. Bartlett PF, Wycherley K and Wong GH. Neurosci Lett Suppl 15, S46 (1984).
4. Steinhoff U and Kaufmann SH. Eur J Immunol 18, 969-972 (1988).
5. Pereira RA, Tscharke DC and Simmons A. J Exp Med 180, 841-850 (1994).
6. Zhang BT, Hikawa N, Horie H and Takenaka T. J Neurosci Res 41, 648-654 (1995).
7. Ozato K, Mayer NM and Sachs DH. Transplantation 34, 113-120 (1982).
8. Bhattacharya A, Dorf ME and Springer TA. J Immunol 127, 2488-2495 (1981).
9. Samuel NM, Mirsky R, Grange JM and Jessen KR. Clin Exp Immunol 68, 500-509 (1987).
10. Armati PJ, Pollard JD and Gatenby P. Muscle Nerve 13, 106-116 (1990).
11. Neumann H, Schmidt H, Cavalie A et al. J Exp Med 185, 305-316 (1997).
12. Gold R, Toyka KV and Hartung HP. Cell Immunol 165, 65-70 (1995).
13. Argall KG, Armati PJ, King NJ and Douglas MW. J Neuroimmunol 35, 273-284 (1991).
14. Mitchell GW, Williams GS, Bosch EP and Hart MN. J Neurol Sci 102, 170-176 (1991).
15. Wekerle H, Schwab M, Linington C and Meyermann R. Eur J Immunol 16, 1551-1557 (1986).
16. Kingston AE, Bergsteinsdottir K, Jessen KR et al. Eur J Immunol 19, 177-183 (1989).
17. Argall KG, Armati PJ, Pollard JD et al. J Neuroimmunol 40, 1-18 (1992).
18. Seliger B, Dunn T, Schwenzer A et al. Scand J Immunol 46, 625-632 (1997).
19. Seliger B, Höhne A, Knuth A et al. Cancer Res 56, 1756-1760 (1996).
20. Fujimaki H, Hikawa N, Nagoya M et al. NeuroReport 7, 2951-2955 (1996).
21. Min W, Pober JS and Johnson DR. J Immunol 156, 3174-3183 (1996).
22. Swift TR. Acta Neuropathol(Berl) 29, 1-8 (1974).
23. Steinhoff U, Schoel B and Kaufmann SH. Int Immunol 2, 279-284 (1990).
24. Neumann H, Schmidt H, Wilharm E et al. J Exp Med 186, 2023-2031 (1997).